Richard F Schlenk, Prof Dr

University Hospital Heidelberg · NCT Trial Center, University Heidelberg · Universitätsklinikum Ulm, for the AML-SG group

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

73 more share only the name and are not shown

Trial papers in acute myeloid leukemia

PubMed author-name match

Trials

Studies that name Richard F Schlenk, Prof Dr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:37 UTC. Open this list on ClinicalTrials.gov

N/A
NCT07148193 · Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Technische Universität Dresden · recruiting · Sarcoma, Survivorship, Quality of Life (QOL) · principal investigator
Ph3
NCT04676243 · Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
University Hospital Heidelberg · withdrawn · Acute Myeloid Leukemia · principal investigator
Ph2
NCT03989713 · Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD
Prof. Dr. Richard F Schlenk · terminated · AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment) · principal investigator
N/A
NCT03549351 · Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
University Hospital Heidelberg · terminated · Leukemia, Myeloid, Acute · principal investigator
N/A
NCT02192619 · National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH · unknown · Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 73 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.